#RETINA GROUP OF FLORIDA SERIES#

Disruption and Destabilization of Meibomian Lipid Films Caused by Increasing Amounts of Ceramides and Cholesterol.

Arciniega JC, Uchiyama E, Butovich IA.

Posterior Necrotizing Scleritis presenting as Sectoral Chorioretinitis.

Stacy RC, Uchiyama E, Jakobiec FA, Sobrin L.

Side effects of Anti-Inflammatory Therapy in Uveitis.

Uchiyama E, Papaliodis GN, Lobo AM, Sobrin L.Accuracy of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) as a research tool for identification of patients with uveitis and scleritis. Uchiyama E, Faez S, Nasir H, Unizony S, Plenge R, Papaliodis GN, Sobrin L.The role of serological titres in the diagnosis of ocular toxoplasmosis. Roh M, Yasa C, Cho H, Nicholson L, Uchiyama E, Young LH, Lobo AM, Papaliodis GN, Durand ML, Sobrin L.

Graefes Arch Clin Exp Ophthalmol 2017 255:2017-21.

#RETINA GROUP OF FLORIDA SERIES#

Pre-papillary vitreous opacities associated with Behçet's disease: a case series and review of the literature. Grotting LA, Davoudi S, Uchiyama E, Lobo AM, Papaliodis GN, Sobrin L.Association of genetic variants in RAB23 and ANXA11 with uveitis in sarcoidosis. Davoudi S, Chang VS, Navarro-Gomez D, Stanwyck LK, Sevgi DD, Papavasileiou E, Ren A, Uchiyama E, Sullivan L, Lobo AM, Papaliodis GN, Sobrin L.Eduardo Uchiyama, MD from Retina Group of Florida- EEUU del Curso Internacional de Retina He is fluent in both English and Spanish. His interests include spending time with his family, reading, traveling and applying science to cooking. Uchiyama is a member of the American Academy of Ophthalmology (AAO), the American Society of Retina Specialists (ASRS), the American Uveitis Society (AUS), the Association for Research in Vision and Ophthalmology (ARVO), and the Pan-American Association of Ophthalmology (PAAO). He is Board Certified by the American Board of Ophthalmology.ĭr. He is a peer reviewer for the journals RETINA and JAMA Ophthalmology. He has been actively involved in clinical research studies and has been published in several scientific journals. His clinical areas of interest include immunomodulatory (steroid-sparing) therapy in uveitis, birdshot retinochoroidopathy, ocular toxoplasmosis, viral retinitis, age-related macular degeneration, diabetic retinopathy, macular surgery and retinal detachment surgery. Upon graduation, he was honored as the “Ophthalmology Fellow of the Year,” an award given at Harvard Medical School for outstanding dedication and contribution to resident education. Uchiyama honed his expertise in the medical and surgical management of patients with ocular inflammatory conditions. Uchiyama accepted a fellowship in Uveitis and Ocular Immunology at Harvard Medical School, with appointments at the Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital. During his last year in Dallas, he served as Chief Retina Fellow and maintained a very active retina practice at two large county hospitals.ĭetermined to expand his skills, Dr. He then completed his Ophthalmology Residency and Vitreoretinal Surgery Fellowship at the University of Texas Southwestern Medical Center/Parkland Memorial Hospital in Dallas, Texas. After relocating to the United States, he undertook three years of postdoctoral research training at the University of Texas Southwestern Medical School. Uchiyama earned his Medical Degree with honors from the Universidad de San Martin de Porres in his native Peru, where he was the recipient of a Teaching and Leadership award that provided tuition scholarship throughout medical school. He also served as an attending physician in the emergency department, where he supervised ophthalmologists-in-training and medical students.ĭr. Eduardo Uchiyama joined the Retina Group of Florida after completing his Uveitis Fellowship at Harvard Medical School and participating in the uveitis referral practice at the Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital in Boston. Iluvien (Fluocinolone Acetonide Implant)ĭr.

Retina group of florida